March 3, 2026

The FOSB-IGFBP5-IGF-1 axis: a novel regulatory pathway that suppresses prostate cancer growth

Prostate cancer growth is suppressed through the FOSB-IGFBP5-IGF-1 regulatory pathway, offering new insights.
Key evidence indicates significant involvement of FOSB and IGFBP5 in modulating IGF-1 levels.
Analysis reveals that manipulating this pathway may lead to innovative treatments for prostate cancer.
Highlights the need for further exploration of this pathway to harness its potential for cancer therapies.

Bookmark

Cite This Study

Huang et al. (Tue,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Oncogenic and osteolytic functions of histone demethylase NO66 in castration-resistant prostate cancer

2019 · 19 citations